Clinical Trials in Tennessee

Showing 10781-10800 of 15,329 trials

Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia

NCT02409459

This study investigates the efficacy and safety of an IV iron Injectafer in the treatment of iron deficient patients with fibromyalgia. Eligible subjects will be randomized in a 1:1 ratio to receive Injectafer or Placebo on days 0 and 5. All treated subjects will be followed for efficacy and safety for 42 days.

Iron DeficiencyFibromyalgia

American Regent, Inc.81 participantsStarted Mar 2015

Franklin, Tennessee, United States

COMPLETEDPhase 129 miles

Autonomic Nervous System and Nitric Oxide Interactions

NCT01137253

The investigators are interested in the role of the autonomic nervous system in the regulation of endothelial function among obese hypertensive subjects. In particular, the investigators will study how endothelial function (response to intra-arterial acetylcholine) changes during autonomic withdrawal.

Endothelial Dysfunction

Vanderbilt University21 participantsStarted Jun 2010

Nashville, Tennessee, United States

COMPLETEDPhase 129 miles

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

NCT00790816

This study is designed to provide continued access to lapatinib as monotherapy or as part of a combination regimen to cancer subjects who are currently participating in a phase I trial that has met its study objectives.

Neoplasms, Breast

Novartis Pharmaceuticals500 participantsStarted Oct 2008

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Santa Monica, California, United States +20 more locations

Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia

Autonomic Nervous System and Nitric Oxide Interactions

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Find Trials by Condition in Tennessee

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer

A Gastrointestinal Quality of Life Study in Lung Transplant Recipients Converted From Mycophenolate Mofetil to Myfortic

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Extension Study of Gelesis100 on Body Weight

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

A Study Evaluating MM-310 in Patients With Solid Tumors

Dropless vs. Standard Drops Contralateral Eye Study

Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501